EPSRC

NEW YORK (GenomeWeb) – The UK government has awarded £3.9 million ($6.6 million) to fund four new research fellowship projects that will that apply engineering techniques to synthetic biology research, the Engineering and Physical Sciences Research Council said on Friday.

NEW YORK (GenomeWeb News) – The UK and China will jointly provide nearly $400,000 to fund several new research activities involving scientists from both countries working collaboratively on synthetic biology projects.

NEW YORK (GenomeWeb News) – The UK is investing £10 million ($15.1 million) to create a new center to drive the translation of synthetic biology research into industrial applications.

NEW YORK (GenomeWeb News) – The Wellcome Trust and the Engineering and Physical Sciences Research Council today announced they are providing £30 million ($47.5 million) in funding for biomedical engineering solutions to address unmet healthcare issues.

NEW YORK (GenomeWeb News) – The UK government plans to provide a boost to the nation's synthetic biology sector under a new initiative that will provide nearly £6.5 million ($10.2 million) in research funding.

NEW YORK (GenomeWeb News) – The UK's Engineering and Physical Sciences Research Council today announced a £5 million ($7.9 million) five-year grant to a consortium of universities to develop a Web-based synthetic biology platform.

A report on public and stakeholder opinion finds citizens excited and worried about synthetic biology but wanting the field to progress with appropriate safeguards and oversight.

A study by the UK's Advanced Institute of Management Research claims that many companies find it increasingly difficult to partner with universities, despite recent efforts by the government to promote such collaboration. Study co-author Ammon Salter discussed the findings with BTW this week.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.